Absence/NN
of/IN
T-cell-/NN
and/CC
B-cell-specific/JJ
transcription/NN
factors/NNS
TCF-1/NN
,/,
GATA-3/NN
,/,
and/CC
BSAP/NN
in/IN
Hodgkin/NN
's/POS
Reed-Sternberg/NN
cells/NNS
./.

Based/VBN
on/IN
the/DT
presence/NN
of/IN
T/NN
cell/NN
receptor-beta/NN
(/(
TcR-beta/NN
)/)
gene/NN
rearrangements/NNS
in/IN
L428/NN
and/CC
HDLM-1/NN
cells/NNS
,/,
the/DT
expression/NN
of/IN
CD2/NN
in/IN
HDLM-1/NN
cells/NNS
,/,
and/CC
the/DT
presence/NN
of/IN
immunoglobulin/NN
heavy-chain/NN
(/(
IgH/NN
)/)
gene/NN
rearrangement/NN
in/IN
KM-H2/NN
cells/NNS
,/,
some/DT
researchers/NNS
have/VBP
concluded/VBN
that/IN
these/DT
long-term/JJ
cell/NN
lines/NNS
derived/VBN
from/IN
patients/NNS
with/IN
Hodgkin/NN
's/POS
disease/NN
are/VBP
lymphoid/JJ
in/IN
nature/NN
./.
=====
The/DT
information/NN
obtained/VBN
from/IN
these/DT
cell/NN
lines/NNS
has/VBZ
also/RB
been/VBN
used/VBN
in/IN
arguments/NNS
for/IN
a/DT
lymphoid/JJ
origin/NN
of/IN
H-RS/NN
cells/NNS
in/IN
tissue/NN
despite/IN
the/DT
frequent/JJ
absence/NN
of/IN
lymphoid/JJ
markers/NNS
and/CC
Ig/TcR/NN
gene/NN
rearrangements/NNS
in/IN
these/DT
cells/NNS
./.
=====
We/PRP
questioned/VBD
whether/IN
one/PRP
can/MD
use/VB
the/DT
limited/JJ
expression/NN
of/IN
lymphoid/JJ
markers/NNS
or/CC
the/DT
limited/JJ
gene/NN
rearrangement/NN
to/TO
conclude/VB
that/IN
H-RS/NN
cells/NNS
have/VBP
a/DT
lymphoid/JJ
origin/NN
,/,
because/IN
these/DT
markers/NNS
may/MD
be/VB
aberrant/JJ
in/IN
tumor/NN
cells/NNS
./.
=====
In/IN
this/DT
study/NN
,/,
we/PRP
examined/VBD
the/DT
expression/NN
of/IN
two/CD
T-cell-specific/JJ
transcription/NN
factors/NNS
(/(
TCF-1/NN
and/CC
GATA-3/NN
)/)
and/CC
one/CD
B-cell-specific/JJ
transcription/NN
factor/NN
(/(
BSAP/NN
)/)
in/IN
cultured/VBN
H-RS/NN
cells/NNS
by/IN
using/VBG
a/DT
gel/NN
mobility/NN
shift/NN
assay/NN
./.
=====
The/DT
sensitivity/NN
and/CC
specificity/NN
of/IN
this/DT
assay/NN
for/IN
determination/NN
of/IN
cell/NN
lineage/NN
have/VBP
been/VBN
established/VBN
in/IN
a/DT
large/JJ
number/NN
of/IN
cultured/VBN
human/JJ
and/CC
murine/JJ
cell/NN
lines/NNS
./.
=====
All/DT
three/CD
types/NNS
of/IN
H-RS/NN
cell/NN
lines/NNS
were/VBD
consistently/RB
negative/JJ
for/IN
BSAP/NN
,/,
TCF-1/NN
,/,
and/CC
GATA-3/NN
./.
=====
The/DT
absence/NN
of/IN
GATA-3/NN
was/VBD
confirmed/VBN
in/IN
H-RS/NN
cells/NNS
in/IN
tissues/NNS
by/IN
an/DT
in/FW
situ/FW
hybridization/NN
technique/NN
./.
=====
Virtually/RB
all/DT
B-cell/NN
lines/NNS
,/,
with/IN
the/DT
exception/NN
of/IN
some/DT
myeloma/NN
cell/NN
lines/NNS
,/,
are/VBP
positive/JJ
for/IN
BSAP/NN
,/,
which/WDT
is/VBZ
the/DT
transcription/NN
factor/NN
for/IN
promoters/NNS
for/IN
several/JJ
B-cell/NN
markers/NNS
,/,
including/VBG
VpreB1/NN
,/,
lambda/NN
5/CD
,/,
CD19/NN
,/,
and/CC
CD20/NN
./.
=====
All/DT
T-cell/NN
lines/NNS
tested/VBN
were/VBD
positive/JJ
for/IN
TCF-1/NN
and/CC
GATA-3/NN
,/,
which/WDT
are/VBP
the/DT
transcription/NN
factors/NNS
for/IN
promoters/NNS
for/IN
several/JJ
T-cell-restricted/JJ
markers/NNS
,/,
including/VBG
CD2/NN
,/,
CD3/NN
,/,
TcR/NN
,/,
and/CC
lck/NN
./.
=====
The/DT
absence/NN
of/IN
BSAP/NN
,/,
TCF-1/NN
,/,
and/CC
GATA-3/NN
clearly/RB
indicates/VBZ
an/DT
underlying/JJ
difference/NN
between/IN
H-RS/NN
cells/NNS
and/CC
lymphoid/JJ
cells/NNS
./.